Robert O'Donnell
University of California, Davis
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert O'Donnell as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:24 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02348255 · NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First RelapseUniversity of California, Davis · withdrawn · Adult Brain Glioblastoma, Recurrent Adult Brain Neoplasm · principal investigator
- Ph1NCT01008566 · Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerNational Cancer Institute (NCI) · completed · Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Localized Non-Resectable Adult Liver Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Immunoliposomal Therapy of non-Hodgkin's LymphomaI01BX000654 · VA · VA NORTHERN CALIFORNIA HEALTH CARE SYS · fiscal years 2012 to 2015Same name and institution; not confirmed by an ID
- PhaseI/II Clinical Trial of hHB22.7 anti-CD22 Monoclonal Antibody for LymphomaR21CA123878 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · fiscal years 2006 to 2007 · $259,395 awarded in 2007Same name and institution; not confirmed by an ID
- Combined modality radioimmunotherapy for nonHodgkins lymphomaP01CA047829 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · fiscal years 1999 to 2000 · $180,509 awarded in 2000Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Integrated Cancer Biology ProgramP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Wolf-Dietrich Heyer · fiscal years 2004 to 2026Named on NCT02348255, NCT01008566
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.